Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank36
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-28.83%
20244.45%
2023-38.33%
2022-110.15%
2021-1693.67%
2020109.84%
201910.18%
20180.53%
2017-375.16%
2016657.36%